kras mutation and glutathion glynac

kras mutation and glutathion glynac Targeting KRAS: from metabolic regulation to cancer treatment | Molecular Cancer Glutathione Depletion and Stalwart Anticancer

Name: kras mutation and glutathion glynac Targeting KRAS: from metabolic regulation to cancer treatment | Molecular Cancer Glutathione Depletion and Stalwart Anticancer
Brand: www.djecji-vrtic-kucica.hr
SKU: 57831769785
Price: 22.47 USD
Availability: InStock
Rating: 4.0477 (18 reviews)

Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors

SKU: 57831769785 · From www.djecji-vrtic-kucica.hr

4.0

USD22.47 USD48.47

Pay in 4 interest-free payments of $5.62 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

confirmed that TFAP2C regulated GPx1 expression by directly binding to the GPx1 promoter, which contains an AP-2 regulatory region, and the methylation of the CpG island in the GPx1 promoter region prevented the binding of TFAP2C by encompassing the AP-2 regulatory region [81]

Hit Identification Hit Identification Validated, high-quality hits, delivered through integrated technologies and expert collaboration, give you a confident starting point for faster drug discovery